NEU 1.52% $12.94 neuren pharmaceuticals limited

Fragile X study, page-2

  1. 10,009 Posts.
    He is doing two things. Proof of Concept. Attracting the attention of big pharma.. NEU's $22M is not enough money to do the heavy lifting needed in this big platform.

    Bells are probably correct that we could see a deal in 2015.

    As WW wrote, 3 successful Phase 2 indications in NEURO SPACE is really big business.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.